She previously served as Chief Executive Officer at Harpoon Therapeutics until the company’s acquisition by Merck in early 2024 ... scientist at the University Hospital of Dusseldorf in Germany and ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for trea ...

Merck KGaA (MKGAY.PK), a German science and technology major, announced that the Phase III MANEUVER trial of pimicotinib, an ...

The focus is on the application of Artificial Intelligence for innovations aimed at making semiconductor processes more sustainable DARMSTADT, Germany, November 07, 2024--(BUSINESS WIRE)--Merck ...

German sci-tech giant Merck is very optimistic about its prospects in the Chinese market and will continue to strengthen its ...

DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany, a leading science and technology company, intensifies the strategic focus of its Electronics business, which operates its ...

DARMSTADT, Germany — Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Intel Corporation, one of the world’s largest semiconductor designers and manufacturers, have begun ...

The focus is on the application of Artificial Intelligence for innovations aimed at making semiconductor processes more sustainable DARMSTADT, Germany, November 07, 2024--(BUSINESS WIRE)--Merck KGaA, ...

Merck (NYSE: MRK) recently reported its Q3 results, with revenues and earnings exceeding the street estimates.

Welcome to the Merck & Company Q3 sales and earnings conference call. [Operator instructions] This call is being recorded.

Oct 17 (Reuters) - German science and technology group Merck (MRCG.DE), opens new tab is open to more acquisitions for its Life Science business after announcing in May it would buy Mirus Bio for ...